Lilly invests $3 billion to expand Wisconsin plant as obesity drug demand soars
Eli Lilly plans to invest $3 billion in expanding its Pleasant Prairie plant to meet high demand for weight-loss and diabetes drugs. The investment will boost production of Zepbound and diabetes treatments.